{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:22:12Z","timestamp":1790785332554,"version":"4.1.0"},"reference-count":75,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T00:00:00Z","timestamp":1656547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>The epidemiology of cardiac amyloidosis (CA), traditionally considered a rare and incurable disease, has changed drastically over the last ten years, particularly due to the advances in diagnostic methods and therapeutic options in the field of transthyretin CA (ATTR-CA). On the one hand, the possibility of employing cardiac scintigraphy with bone tracers to diagnose ATTR-CA without a biopsy has unveiled the real prevalence of the disease; on the other, the emergence of effective treatments, such as tafamidis, has rendered an early and accurate diagnosis critical. Interestingly, the following subgroups of patients have been found to have a higher prevalence of CA: elderly subjects &gt; 75 years, patients with cardiac hypertrophy hospitalized for heart failure with preserved ejection fraction, subjects operated on for bilateral carpal tunnel syndrome, patients with cardiac hypertrophy not explained by concomitant factors and individuals with aortic valve stenosis. Many studies investigating the prevalence of CA in these particular populations have contributed to rewriting the epidemiology of the disease, increasing the awareness of the medical community for a previously underappreciated condition. In this review, we summarized the latest evidence on the epidemiology of CA according to the different clinical settings typically associated with the disease.<\/jats:p>","DOI":"10.3390\/biomedicines10071566","type":"journal-article","created":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T20:53:02Z","timestamp":1656622382000},"page":"1566","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Re-Definition of the Epidemiology of Cardiac Amyloidosis"],"prefix":"10.3390","volume":"10","author":[{"given":"Maddalena","family":"Rossi","sequence":"first","affiliation":[{"name":"Center for Diagnosis and Treatment of Cardiomyopathies, Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano-Isontina (ASUGI) and University of Trieste, 34149 Trieste, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guerino Giuseppe","family":"Varr\u00e0","sequence":"additional","affiliation":[{"name":"Center for Diagnosis and Treatment of Cardiomyopathies, Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano-Isontina (ASUGI) and University of Trieste, 34149 Trieste, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3307-0825","authenticated-orcid":false,"given":"Aldostefano","family":"Porcari","sequence":"additional","affiliation":[{"name":"Center for Diagnosis and Treatment of Cardiomyopathies, Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano-Isontina (ASUGI) and University of Trieste, 34149 Trieste, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Saro","sequence":"additional","affiliation":[{"name":"Center for Diagnosis and Treatment of Cardiomyopathies, Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano-Isontina (ASUGI) and University of Trieste, 34149 Trieste, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Pagura","sequence":"additional","affiliation":[{"name":"Center for Diagnosis and Treatment of Cardiomyopathies, Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano-Isontina (ASUGI) and University of Trieste, 34149 Trieste, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8135-6874","authenticated-orcid":false,"given":"Andrea","family":"Lalario","sequence":"additional","affiliation":[{"name":"Center for Diagnosis and Treatment of Cardiomyopathies, Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano-Isontina (ASUGI) and University of Trieste, 34149 Trieste, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6986-2459","authenticated-orcid":false,"given":"Franca","family":"Dore","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Azienda Sanitaria Universitaria Giuliano-Isontina (ASUGI) and University of Trieste, 34149 Trieste, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8241-9726","authenticated-orcid":false,"given":"Rossana","family":"Bussani","sequence":"additional","affiliation":[{"name":"Center for Diagnosis and Treatment of Cardiomyopathies, Cardiothoracic Department, Institute of Pathological Anatomy and Histology, Azienda Sanitaria Universitaria Giuliano-Isontina (ASUGI), University of Trieste, 34149 Trieste, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianfranco","family":"Sinagra","sequence":"additional","affiliation":[{"name":"Center for Diagnosis and Treatment of Cardiomyopathies, Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano-Isontina (ASUGI) and University of Trieste, 34149 Trieste, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Merlo","sequence":"additional","affiliation":[{"name":"Center for Diagnosis and Treatment of Cardiomyopathies, Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano-Isontina (ASUGI) and University of Trieste, 34149 Trieste, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,6,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1056\/NEJMra023144","article-title":"Molecular Mechanisms of Amyloidosis","volume":"349","author":"Merlini","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ejim.2020.09.025","article-title":"Transthyretin amyloid cardiomyopathy: An uncharted territory awaiting discovery","volume":"82","author":"Porcari","year":"2020","journal-title":"Eur. J. Intern. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1080\/13506129.2018.1549825","article-title":"Amyloid nomenclature 2018: Recommendations by the International Society of Amyloidosis (ISA) nomenclature committee","volume":"25","author":"Benson","year":"2018","journal-title":"Amyloid"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Canepa, M., Vianello, P.F., Porcari, A., Merlo, M., and Scarpa, M. (2022). Cardiac amyloidosis: A changing epidemiology with open challenges. Vessel Plus, 6.","DOI":"10.20517\/2574-1209.2021.106"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","article-title":"Nonbiopsy diagnosis of cardiac transthyretin amyloidosis","volume":"133","author":"Gillmore","year":"2016","journal-title":"Circulation"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s40119-021-00222-w","article-title":"Multidisciplinary Approaches for Transthyretin Amyloidosis","volume":"10","author":"Koike","year":"2021","journal-title":"Cardiol. Ther."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e173","DOI":"10.1093\/eurjpc\/zwab127","article-title":"A national survey on prevalence of possible echocardiographic red flags of amyloid cardiomyopathy in consecutive patients undergoing routine echocardiography: Study design and patients characterization-the first insight from the AC-TIVE Study","volume":"29","author":"Merlo","year":"2021","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Merlo, M., Pagura, L., Porcari, A., Cameli, M., Vergaro, G., Musumeci, B., Biagini, E., Canepa, M., Crotti, L., and Imazio, M. (2022). Unmasking the Prevalence of Amyloid Cardiomyopathy in the Real World: Results from Phase 2 of AC-TIVE Study, an Italian Nationwide Survey. Eur. J. Heart Fail., 24.","DOI":"10.1093\/eurheartj\/suac011.062"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1185\/03007995.2012.754348","article-title":"THAOS\u2013The Transthyretin Amyloidosis Outcomes Survey: Initial report on clinical manifestations in patients with hereditary and wild-type transthyretin amyloidosis","volume":"29","author":"Coelho","year":"2012","journal-title":"Curr. Med. Res. Opin."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Pozsonyi, Z., Pesk\u00f3, G., Tak\u00e1cs, H., Csuka, D., Nagy, V., Szil\u00e1gyi, \u00c1., Hategan, L., Muk, B., Cs\u00e1nyi, B., and Nyolczas, N. (2021). Variant Transthyretin Amyloidosis (ATTRv) in Hungary: First Data on Epidemiology and Clinical Features. Genes, 12.","DOI":"10.3390\/genes12081152"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Porcari, A., Pagura, L., Varr\u00e0, G.G., Rossi, M., Longo, F., Saro, R., Barbisan, D., Cittar, M., Rapezzi, C., and Merlo, M. (2022). Grey zones in the supportive treatments of cardiac amyloidosis. Vessel Plus, 6.","DOI":"10.20517\/2574-1209.2021.134"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jcmg.2014.03.004","article-title":"Identification of TTR-related subclinical amyloidosis with 99mTc-DPD scintigraphy","volume":"7","author":"Longhi","year":"2014","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s12350-021-02575-0","article-title":"The prevalence of TTR cardiac amyloidosis among patients undergoing bone scintigraphy","volume":"28","author":"Bianco","year":"2021","journal-title":"J. Nucl. Cardiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ijcard.2018.06.006","article-title":"Prevalence of wild type ATTR assessed as myocardial uptake in bone scan in the elderly population","volume":"270","author":"Vioque","year":"2018","journal-title":"Int. J. Cardiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1007\/s12350-020-02152-x","article-title":"Estimation of prevalence of transthyretin (ATTR) cardiac amyloidosis in an Australian subpopulation using bone scans with echocardiography and clinical correlation","volume":"28","author":"Cuscaden","year":"2021","journal-title":"J. Nucl. Cardiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1007\/s12350-019-01760-6","article-title":"ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging","volume":"26","author":"Dorbala","year":"2019","journal-title":"J. Nucl. Cardiol."},{"key":"ref_18","first-page":"424","article-title":"I dieci punti che il cardiologo deve conoscere su scintigrafia miocardica con traccianti ossei, amiloidosi e cuore","volume":"23","author":"Porcari","year":"2022","journal-title":"G Ital. Cardiol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Mattana, F., Muraglia, L., Girardi, F., Cerio, I., Porcari, A., Dore, F., Bonfiglioli, R., and Fanti, S. (2022). Clinical application of cardiac scintigraphy with bone tracers: Controversies and pitfalls in cardiac amyloidosis. Vessel Plus, 6.","DOI":"10.20517\/2574-1209.2021.87"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Porcari, A., Bussani, R., Merlo, M., Varr\u00e0, G.G., Pagura, L., Rozze, D., and Sinagra, G. (2021). Incidence and Characterization of Concealed Cardiac Amyloidosis Among Unselected Elderly Patients Undergoing Post-mortem Examination. Front. Cardiovasc. Med., 8.","DOI":"10.3389\/fcvm.2021.749523"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/mus.26145","article-title":"Carpal tunnel release: Lifetime prevalence, annual incidence, and risk factors","volume":"58","author":"Pourmemari","year":"2018","journal-title":"Muscle Nerve"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1161\/CIRCULATIONAHA.108.843334","article-title":"Systemic cardiac amyloidoses: Disease profiles and clinical courses of the 3 main types","volume":"120","author":"Rapezzi","year":"2009","journal-title":"Circulation"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1007\/s00392-019-01467-1","article-title":"Carpal tunnel syndrome and spinal canal stenosis: Harbingers of transthyretin amyloid cardiomyopathy?","volume":"108","author":"Siepen","year":"2019","journal-title":"Clin. Res. Cardiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jacc.2016.03.596","article-title":"Genotype and Phenotype of Transthyretin Cardiac Amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey)","volume":"68","author":"Maurer","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jacc.2019.04.054","article-title":"Association of Carpal Tunnel Syndrome With Amyloidosis, Heart Failure, and Adverse Cardiovascular Outcomes","volume":"74","author":"Leicht","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/ehf2.13606","article-title":"Prognostic significance of unexplained left ventricular hypertrophy in patients undergoing carpal tunnel surgery","volume":"9","author":"Porcari","year":"2022","journal-title":"ESC Heart Fail."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s12265-019-09895-0","article-title":"Prevalence of Cardiac Amyloidosis in Patients with Carpal Tunnel Syndrome","volume":"12","author":"Moral","year":"2019","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ijcard.2020.12.044","article-title":"Prevalence of transthyretin amyloid cardiomyopathy in male patients who underwent bilateral carpal tunnel surgery: The ACTUAL study","volume":"329","author":"Vianello","year":"2021","journal-title":"Int. J. Cardiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/ejhf.1742","article-title":"Carpal tunnel syndrome in cardiac amyloidosis: Implications for early diagnosis and prognostic role across the spectrum of aetiologies","volume":"22","author":"Milandri","year":"2020","journal-title":"Eur. J. Heart Fail."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1002\/ejhf.1858","article-title":"Epidemiology of heart failure","volume":"22","author":"Groenewegen","year":"2020","journal-title":"Eur. J. Heart Fail."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"H142","DOI":"10.1093\/eurheartj\/suaa080","article-title":"Cardiac amyloidosis: Do not forget to look for it","volume":"22","author":"Porcari","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1080\/07853890701842988","article-title":"Senile systemic amyloidosis affects 25% of the very aged and associates with genetic variation in alpha2-macroglobulin and tau: A population-based autopsy study","volume":"40","author":"Tanskanen","year":"2008","journal-title":"Ann. Med."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Mohammed, S.F., Mirzoyev, S.A., Edwards, W.D., Dogan, A., Grogan, D.R., Dunlay, S.M., Roger, V.L., Gertz, M.A., Dispenzieri, A., and Zeldenrust, S.R. (2014). Left Ventricular Amyloid Deposition in Patients with Heart Failure and Preserved Ejection Fraction. JACC Heart Fail., 2.","DOI":"10.1016\/j.jchf.2013.11.004"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Gilstrap, L.G., Dominici, F., Wang, Y., El-Sady, M.S., Singh, A., Di Carli, M.F., Falk, R.H., and Dorbala, S. (2019). Epidemiology of Cardiac Amyloidosis Associated Heart Failure Hospitalizations Among Fee-for-Service Medicare Beneficiaries in the United States. Circ. Heart Fail., 12.","DOI":"10.1161\/CIRCHEARTFAILURE.118.005407"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1093\/eurheartj\/ehv338","article-title":"Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction","volume":"36","author":"Robles","year":"2015","journal-title":"Eur. Heart J."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Lindmark, K., Pilebro, B., Sundstr\u00f6m, T., and Lindqvist, P. (2021). Prevalence of wild type transtyrethin cardiac amyloidosis in a heart failure clinic. ESC Heart Fail., 8.","DOI":"10.1002\/ehf2.13110"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"AbouEzzeddine, O.F., Davies, D.R., Scott, C.G., Fayyaz, A.U., Askew, J.W., McKie, P.M., Noseworthy, P.A., Johnson, G.B., Dunlay, S.M., and Borlaug, B.A. (2021). Prevalence of Transthyretin Amyloid Cardiomyopathy in Heart Failure With Preserved Ejection Fraction. JAMA Cardiol., 6.","DOI":"10.1001\/jamacardio.2021.3070"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Hahn, V.S., Yanek, L.R., Vaishnav, J., Ying, W., Vaidya, D., Lee, Y.Z.J., Riley, S.J., Subramanya, V., Brown, E.E., and Hopkins, C.D. (2020). Endomyocardial Biopsy Characterization of Heart Failure with Preserved Ejection Fraction and Prevalence of Cardiac Amyloidosis. JACC Heart Fail., 8.","DOI":"10.1016\/j.jchf.2020.04.007"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Dungu, J.N., Papadopoulou, S.A., Wykes, K., Mahmood, I., Marshall, J., Valencia, O., Fontana, M., Whelan, C.J., Gillmore, J.D., and Hawkins, P.N. (2016). Afro-Caribbean Heart Failure in the United Kingdom: Cause, Outcomes, and ATTR V122I Cardiac Amyloidosis. Circ. Heart Fail., 9.","DOI":"10.1161\/CIRCHEARTFAILURE.116.003352"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1080\/13506129.2019.1625322","article-title":"Prevalence of cardiac amyloidosis among elderly patients with systolic heart failure or conduction disorders","volume":"26","author":"Sainz","year":"2019","journal-title":"Amyloid"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Goland, S., Volodarsky, I., Fabricant, Y., Livschitz, S., Tshori, S., Cuciuc, V., Zilberman, L., Fugenfirov, I., Meledin, V., and Shimoni, S. (2021). Wild-type TTR amyloidosis among patients with unexplained heart failure and systolic LV dysfunction. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0254104"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1016\/j.jacc.2019.09.056","article-title":"Aortic Stenosis and Cardiac Amyloidosis: JACC Review Topic of the Week","volume":"74","author":"Ternacle","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.carpath.2009.04.005","article-title":"High prevalence of amyloid in 150 surgically removed heart valves--a comparison of histological and clinical data reveals a correlation to atheroinflammatory conditions","volume":"19","author":"Kristen","year":"2010","journal-title":"Cardiovasc. Pathol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/j.1365-2559.2012.04265.x","article-title":"Amyloid substance within stenotic aortic valves promotes mineralization","volume":"61","author":"Audet","year":"2012","journal-title":"Histopathology"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Treibel, T.A., Fontana, M., Gilbertson, J.A., Castelletti, S., White, S.K., Scully, P.R., Roberts, N., Hutt, D.F., Rowczenio, D.M., and Whelan, C.J. (2016). Occult Transthyretin Cardiac Amyloid in Severe Calcific Aortic Stenosis: Prevalence and Prognosis in Patients Undergoing Surgical Aortic Valve Replacement. Circ. Cardiovasc. Imaging, 9.","DOI":"10.1161\/CIRCIMAGING.116.005066"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jaccao.2021.08.008","article-title":"Concomitant Transthyretin Amyloidosis and Severe Aortic Stenosis in Elderly Indian Population: A Pilot Study","volume":"3","author":"Singal","year":"2021","journal-title":"JACC CardioOncol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1093\/eurheartj\/ehx350","article-title":"Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement","volume":"38","author":"Narotsky","year":"2017","journal-title":"Eur. Heart J."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Scully, P.R., Treibel, T., Fontana, M., Lloyd, G., Mullen, M., Pugliese, F., Hartman, N., Hawkins, P.N., Menezes, L., and Moon, J.C. (2018). Prevalence of Cardiac Amyloidosis in Patients Referred for Transcatheter Aortic Valve Replacement. J. Am. Coll. Cardiol., 71.","DOI":"10.1016\/j.jacc.2017.11.037"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jacc.2020.11.006","article-title":"Prevalence and Outcomes of Concomitant Aortic Stenosis and Cardiac Amyloidosis","volume":"77","author":"Nitsche","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Cavalcante, J.L., Rijal, S., Abdelkarim, I., Althouse, A.D., Sharbaugh, M.S., Fridman, Y., Soman, P., Forman, D.E., Schindler, J.T., and Gleason, T.G. (2017). Cardiac amyloidosis is prevalent in older patients with aortic stenosis and carries worse prognosis. J. Cardiovasc. Magn. Reson., 19.","DOI":"10.1186\/s12968-017-0415-x"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Ruberg, F.L., Grogan, M., Hanna, M., Kelly, J.W., and Maurer, M.S. (2019). Transthyretin Amyloid Cardiomyopathy: JACC State-of-the-Art Review. J. Am. Coll. Cardiol., 73.","DOI":"10.1016\/j.jacc.2019.04.003"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Canepa, M., Fumagalli, C., Tini, G., Vincent-Tompkins, J., Day, S.M., Ashley, E.A., Mazzarotto, F., Ware, J.S., Michels, M., and Jacoby, D. (2020). Temporal Trend of Age at Diagnosis in Hypertrophic Cardiomyopathy: An Analysis of the International Sarcomeric Human Cardiomyopathy Registry. Circ. Heart Fail., 13.","DOI":"10.1161\/CIRCHEARTFAILURE.120.007230"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ijcard.2019.07.051","article-title":"Prevalence of cardiac amyloidosis among adult patients referred to tertiary centres with an initial diagnosis of hypertrophic cardiomyopathy","volume":"300","author":"Maurizi","year":"2020","journal-title":"Int. J. Cardiol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/13506129.2017.1333956","article-title":"Diagnostic score for the detection of cardiac amyloidosis in patients with left ventricular hypertrophy and impact on prognosis","volume":"24","author":"Cariou","year":"2017","journal-title":"Amyloid"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1093\/eurheartj\/ehv583","article-title":"Prevalence and clinical phenotype of hereditary transthyretin amyloid cardiomyopathy in patients with increased left ventricular wall thickness","volume":"37","author":"Damy","year":"2016","journal-title":"Eur. Heart J."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/0002-9149(87)91151-9","article-title":"Dynamic left ventricular outflow tract obstruction in cardiac amyloidosis detected by continuous-wave Doppler echocardiography","volume":"59","author":"Oh","year":"1987","journal-title":"Am. J. Cardiol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.euje.2005.09.002","article-title":"Dynamic left ventricular outflow tract obstruction in senile cardiac amyloidosis","volume":"7","author":"Mookadam","year":"2006","journal-title":"Eur. J. Echocardiogr."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/j.amjcard.2014.07.058","article-title":"Impact of Incidental Amyloidosis on the Prognosis of Patients With Hypertrophic Cardiomyopathy Undergoing Septal Myectomy for Left Ventricular Outflow Tract Obstruction","volume":"114","author":"Helder","year":"2014","journal-title":"Am. J. Cardiol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.jacc.2016.06.053","article-title":"AL (Light-Chain) Cardiac Amyloidosis: A Review of Diagnosis and Therapy","volume":"68","author":"Falk","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1056\/NEJMe1508746","article-title":"Out, Out\u2014Making Amyloid\u2019s Candle Briefer","volume":"373","author":"Comenzo","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.jchf.2019.04.010","article-title":"Screening for Transthyretin Amyloid Cardiomyopathy in Everyday Practice","volume":"7","author":"Witteles","year":"2019","journal-title":"JACC Heart Fail."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.mayocp.2018.08.041","article-title":"Incidence of AL Amyloidosis in Olmsted County, Minnesota, 1990 through 2015","volume":"94","author":"Kyle","year":"2019","journal-title":"Mayo Clin. Proc."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ijcard.2021.04.023","article-title":"Changes in the perceived epidemiology of amyloidosis: 20 year-experience from a Tertiary Referral Centre in Tuscany","volume":"335","author":"Zampieri","year":"2021","journal-title":"Int. J. Cardiol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1002\/ehf2.13411","article-title":"Current patterns of beta-blocker prescription in cardiac amyloidosis: An Italian nationwide survey","volume":"8","author":"Tini","year":"2021","journal-title":"ESC Heart Fail."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/eurheartj\/ehab072","article-title":"Diagnosis and treatment of cardiac amyloidosis: A position statement of the ESC Working Group on Myocardial and Pericardial Diseases","volume":"42","author":"Rapezzi","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1373\/clinchem.2008.117143","article-title":"Identification of amyloidogenic light chains requires the combination of serum-free light chain assay with immunofixation of serum and urine","volume":"55","author":"Palladini","year":"2009","journal-title":"Clin. Chem."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/j.mayocp.2017.09.016","article-title":"Prevalence of Monoclonal Gammopathy in Wild-Type Transthyretin Amyloidosis","volume":"92","author":"Geller","year":"2017","journal-title":"Mayo Clin. Proc."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/13506129.2019.1693359","article-title":"Causes of AA amyloidosis: A systematic review","volume":"27","author":"Brunger","year":"2020","journal-title":"Amyloid"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0002-9149(97)89403-9","article-title":"Electrocardiography and Doppler echocardiography in secondary (AA) amyloidosis","volume":"77","author":"Dubrey","year":"1996","journal-title":"Am. J. Cardiol."},{"key":"ref_71","unstructured":"Hassan, W., Al-Sergani, H., Mourad, W., and Tabbaa, R. (2005). Amyloid Heart Disease: New Frontiers and Insights in Pathophysiology, Diagnosis, and Management. Tex. Heart Inst. J., 32, Available online: https:\/\/pubmed.ncbi.nlm.nih.gov\/16107109\/."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1002\/ejhf.2380","article-title":"Standardizing the role of endomyocardial biopsy in current clinical practice worldwide","volume":"23","author":"Sinagra","year":"2021","journal-title":"Eur. J. Heart Fail."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Porcari, A., Allegro, V., Pagura, L., Longo, F., Rossi, M., Varra, G.G., Dore, F., Bussani, R., Merlo, M., and Sinagra, G. (2021). 201 Clinical presentation profiles and natural history of cardiac amyloidosis: Long-term monocentric analysis (1990\u20132020). Eur. Heart J., 23.","DOI":"10.1093\/eurheartj\/suab142.043"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.jacc.2022.01.036","article-title":"Critical Comparison of Documents From Scientific Societies on Cardiac Amyloidosis: JACC State-of-the-Art Review","volume":"79","author":"Rapezzi","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"E7","DOI":"10.1161\/CIR.0000000000000792","article-title":"Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement from the American Heart Association","volume":"142","author":"Kittleson","year":"2020","journal-title":"Circulation"}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/10\/7\/1566\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:41:24Z","timestamp":1760139684000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/10\/7\/1566"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,30]]},"references-count":75,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,7]]}},"alternative-id":["biomedicines10071566"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines10071566","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,30]]}}}